Document is current
Any future updates will be listed below
-
Authors
Rennie, Stuart
Chege, Wairimu
Schrumpf, Leah A.
Luna, Florencia
Klitzman, Robert
Moseki, Ernest
Brown, Brandon
Wakefield, Steven
Sugarman, Jeremy http://orcid.org/0000-0001-7022-8332
-
Funding
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (UM1AI068613, UM1AI068617, UM1AI068619)
National Institute of Allergy and Infectious Diseases (UM1AI068613, UM1AI068617, UM1AI068619)
-
License Information
Text and Data Mining valid from 2021-01-25
Version of Record valid from 2021-01-25
-
More Information
Article History
Received: 14 July 2020
Accepted: 14 January 2021
First Online: 25 January 2021
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: Jeremy Sugarman is a member of Merck KGaA’s the Bioethics Advisory Panel and Stem Cell Research Oversight Committee; is a member of IQVIA’s Ethics Advisory Panel; is a member of Aspen Neurosciences Scientific Advisory Board; is a consultant to Biogen; and has consulted for Portola Pharmaceuticals, Inc.. No other authors have declared conflicting interests.
